Description
A study aimed at determining the avidity of class IgG antibodies to the capsid protein (VCA) of the Epstein-Barr virus to assess the duration of a primary infection and for the differential diagnosis of an acute infection from a past one or its reactivation (exacerbation).
Period of execution
Within 9 days. The specified time does not include the day of biomaterial collection
Biomaterial type